Pregnancy with congenital heart disease

Abstract

Pregnancy is complicated by maternal cardiovascular disease in 1%-4% of cases. With advances in management of congenital heart diseases (CHDs), the survival to adulthood and childbearing age is increasing all over the world. The physiological adaptation during pregnancy adds to the hemodynamic burden of CHD, and, hence, many women are diagnosed with CHD for the first time during pregnancy, more so in developing countries. The type of underlying CHD and pre-pregnancy hemodynamics determine the risk of developing complications during pregnancy. Hence, pre-pregnancy risk stratification and counseling are a crucial part of management plan. Some of the serious CHDs are best treated in the preconception stage. The maximum chance of developing complications is between 28 and 32 weeks of gestation, during labor, and up to two weeks after delivery. Common complications in women with CHD during pregnancy and labor include heart failure, arrhythmias, bleeding/thrombosis, infective endocarditis, and rarely maternal death. Fetal complications include abortion, stillbirth, prematurity, low birth weight, and CHD. Comprehensive knowledge of these complications and their management is very important as an experienced multidisciplinary team is critical for improving outcome of these patients. Special care is required for pregnant women who have pulmonary hypertension, due to either Eisenmenger syndrome or other causes, severe valve stenosis, aortopathy associated with bicuspid aortic valve/coarctation, or severe cyanotic CHDs. Most women with CHD are at low risk, and successful pregnancy is feasible in the majority with optimal management.

Keywords

Adult congenital heart disease / maternal cardiac disease / maternal mortality / maternal morbidity / risk stratification / pregnancy complications

References

[1] Regitz-Zagrosek V,Bauersachs J.ESC Scientific Document Group2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.Eur Heart J2018;39:3165-241

[2] Knight M,Tuffnell D,Kenyon S. on behalf of MBRRACE-UK Saving lives, improving mothers’ care-lessons learned to inform maternity care from the UK and Ireland confidential enquiries into maternal deaths and morbidity 2013-15. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2017.

[3] Roos-Hesselink J,Johnson M.Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC).Eur Heart J2019;40:3848-55

[4] Stout KK,Aboulhosn JA.2018 AHA/ACC Guideline for the management of adults with congenital heart disease: a report of the American college of cardiology/American Heart Association task force on clinical practice guidelines.J Am Coll Cardiol2019;73:e81-e192

[5] Greutmann M.Pregnancy in women with congenital heart disease.Eur Heart J2015;36:2491-9

[6] Heemelaar S,Knight M.Maternal mortality due to cardiac disease in low- and middle-income countries.Trop Med Int Health2020;25:673-86 PMCID:PMC7318167

[7] Bhatla N,Behera G.Cardiac disease in pregnancy.Int J Gynecol Obstet2003;82:153-9

[8] Subbaiah M,Kumar S.Heart disease in pregnancy: cardiac and obstetric outcomes.Arch Gynecol Obstet2013;288:23-7

[9] Say L,Gemmill A.Global causes of maternal death: a WHO systematic analysis.Lancet Glob Health2014;2:e323-33

[10] Kempny A,Uebing A.Outcome of cardiac surgery in patients with congenital heart disease in England between 1997 and 2015.PLoS One2017;12:e0178963 PMCID:PMC5476245

[11] Zilla P,Yacoub MH.The Cape Town declaration on access to cardiac surgery in the developing world.Eur J Cardiothorac Surg2018;54:407-10

[12] Sliwa K,Sinning C.Pregnant women with uncorrected congenital heart disease: heart failure and mortality.JACC Heart Fail2020;8:100-10

[13] Schlichting LE,Zaidi AN,Van Zutphen AR.Maternal comorbidities and complications of delivery in pregnant women with congenital heart disease.J Am Coll Cardiol2019;73:2181-91

[14] Ramage K,Silversides C,Metcalfe A.Association of adult congenital heart disease with pregnancy, maternal, and neonatal outcomes.JAMA Netw Open2019;2:e193667 PMCID:PMC6512464

[15] Pfaller B,Grewal J.Preventing complications in pregnant women with cardiac disease.J Am Coll Cardiol2020;75:1443-52

[16] Cornette J,Rossi A.Hemodynamic adaptation to pregnancy in women with structural heart disease.Int J Cardiol2013;168:825-31

[17] Duvekot JJ.Maternal cardiovascular hemodynamic adaptation to pregnancy.Obstet Gynecol Surv1994;49:S1-14

[18] Ueland K.Circulatory changes in pregnancy.Clin Obstet Gynecol1975;18:41-50

[19] Pieper PG,Aarnoudse JG.ZAHARA II investigatorsUteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease.Circulation2013;128:2478-87

[20] Niwa K.Adult congenital heart disease with pregnancy.Korean Circ J2018;48:251-76 PMCID:PMC5889976

[21] Niwa K,Akagi T.Arrhythmia and reduced heart rate variability during pregnancy in women with congenital heart disease and previous reparative surgery.Int J Cardiol2007;122:143-8

[22] Ramlakhan KP,Lelonek M.Congenital heart disease in the ESC EORP registry of pregnancy and cardiac disease (ROPAC).Int J Cardiol Cong2021;3:100107

[23] Niwa K,Bhuta SM.Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses.Circulation2001;103:393-400

[24] Katsuragi S,Yamanaka K.Pregnancy-associated aortic dilatation or dissection in Japanese women with Marfan syndrome.Circ J2011;75:2545-51

[25] Simpson EL,Nightingale AL.Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database.BJOG2001;108:56-60

[26] Ohuchi H,Kamiya C.Cardiopulmonary variables during exercise predict pregnancy outcome in women with congenital heart disease.Circ J2013;77:470-6

[27] Lui GK,Khairy P.Alliance for Adult Research in Congenital Cardiology (AARCC)Heart rate response during exercise and pregnancy outcome in women with congenital heart disease.Circulation2011;123:242-8

[28] Kampman MA,van Veldhuisen DJ.ZAHARA II investigatorsN-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease.Eur Heart J2014;35:708-15

[29] Siu SC,Colman JM.Cardiac Disease in Pregnancy (CARPREG) InvestigatorsProspective multicenter study of pregnancy outcomes in women with heart disease.Circulation2001;104:515-21

[30] Drenthen W,Balci A.ZAHARA InvestigatorsPredictors of pregnancy complications in women with congenital heart disease.Eur Heart J2010;31:2124-32

[31] Drenthen W,Roos-Hesselink JW.ZAHARA InvestigatorsOutcome of pregnancy in women with congenital heart disease: a literature review.J Am Coll Cardiol2007;49:2303-11

[32] Fesslova V,Lalatta F.Recurrence of congenital heart disease in cases with familial risk screened prenatally by echocardiography.J Pregnancy2011;2011:368067 PMCID:PMC3184425

[33] Gill HK,Sharland GK.Patterns of recurrence of congenital heart disease: an analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography.J Am Coll Cardiol2003;42:923-9

[34] Pierpont ME,Chung WK.American Heart Association Council on Cardiovascular Disease in the YoungCouncil on Cardiovascular and Stroke NursingCouncil on Genomic and Precision MedicineGenetic basis for congenital heart disease: revisited: a scientific statement from the American Heart Association.Circulation2018;138:e653-711 PMCID:PMC6555769

[35] Commission on Radiological Protection. Pregnancy and medical radiation. ICRP publication 84.Ann ICRP2000;30:1-43

[36] Ruys TPE,Pijuan-Domènech A.Is a planned caesarean section in women with cardiac disease beneficial?.Heart2015;101:530-6

[37] Canobbio MM,Aboulhosn J.American Heart Association Council on Cardiovascular and Stroke NursingCouncil on Clinical CardiologyCouncil on Cardiovascular Disease in the YoungCouncil on Functional Genomics and Translational BiologyCouncil on Quality of Care and Outcomes ResearchManagement of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association.Circulation2017;135:e50-87

[38] Ruys TP,Hall R.Heart failure in pregnant women with cardiac disease: data from the ROPAC.Heart2014;100:231-8

[39] Wieseler KM,Kanal KM,Stewart BK.Imaging in pregnant patients: examination appropriateness.Radiographics2010;30:1215-29; discussion 1230

[40] Hosseini S,Samiei N.Feto-maternal outcomes of urgent open-heart surgery during pregnancy.J Heart Valve Dis2015;24:253-9

[41] Chan WS,Ginsberg JS.Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature.Arch Intern Med2000;160:191-6

[42] Hassouna A.Limited dose warfarin throughout pregnancy in patients with mechanical heart valve prosthesis: a meta-analysis.Interact Cardiovasc Thorac Surg2014;18:797-806

[43] Kuijpers JM,Groenink M.Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material.Eur Heart J2017;38:2048-56

[44] Bédard E,Gatzoulis MA.Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?.Eur Heart J2009;30:256-65

[45] Weiss BM,Seifert B.Outcome of Pulmonary Vascular Disease in Pregnancy: A Systematic Overview From 1978 Through 1996.J Am Coll Cardiol1998;31:1650-7

[46] Duan R,Wang X.Pregnancy outcome in women with Eisenmenger's syndrome: a case series from west China.BMC Pregnancy Childbirth2016;16:356 PMCID:PMC5112756

[47] Sliwa K,Budts W.ROPAC investigatorsPulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology.Eur J Heart Fail2016;18:1119-28

[48] Akagi T.Pregnancy related cardiovascular complications in women with post operative tetralogy of Fallot: multiinstitutional survey in Japan.Circulation2005;108:682

[49] Presbitero P,Stone S,Spiegelhalter D.Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus.Circulation1994;89:2673-6

[50] Orwat S,van Hagen IM.ROPAC InvestigatorsRisk of pregnancy in moderate and severe aortic stenosis: from the multinational ROPAC registry.J Am Coll Cardiol2016;68:1727-37

[51] Beauchesne LM,Ammash NM.Coarctation of the aorta: outcome of pregnancy.J Am Coll Cardiol2001;38:1728-33

[52] Guédès A,Leduc L,Marcotte F.Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries.J Am Coll Cardiol2004;44:433-7

[53] Drenthen W,van der Tuuk K.Zahara InvestigatorsCardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects.Eur Heart J2005;26:2581-7

[54] Lima FV,Yen TY.Clinical characteristics and outcomes in pregnant women with Ebstein anomaly at the time of delivery in the USA: 2003-2012.Arch Cardiovasc Dis2016;109:390-8